Cookie Hinweis

Wir verwenden Cookies, um Ihnen ein optimales Webseiten-Erlebnis zu bieten. Dazu zählen Cookies, die für den Betrieb der Seite notwendig sind, sowie solche, die lediglich zu anonymen Statistikzwecken, für Komforteinstellungen oder zur Anzeige personalisierter Inhalte genutzt werden. Sie können selbst entscheiden, welche Kategorien Sie zulassen möchten. Bitte beachten Sie, dass auf Basis Ihrer Einstellungen womöglich nicht mehr alle Funktionalitäten der Seite zur Verfügung stehen. Weitere Informationen finden Sie in unseren Datenschutzhinweisen .


Diese Cookies sind für die Funktionalität unserer Website erforderlich und können nicht deaktiviert werden.

Name Webedition CMS
Zweck Dieses Cookie wird vom CMS (Content Management System) Webedition für die unverwechselbare Identifizierung eines Anwenders gesetzt. Es bietet dem Anwender bessere Bedienerführung, z.B. Speicherung von Sucheinstellungen oder Formulardaten. Typischerweise wird dieses Cookie beim Schließen des Browsers gelöscht.
Name econda
Zweck Session-Cookie für die Webanalyse Software econda. Diese läuft im Modus „Anonymisiertes Messen“.

Diese Cookies helfen uns zu verstehen, wie Besucher mit unserer Webseite interagieren, indem Informationen anonym gesammelt und analysiert werden. Je nach Tool werden ein oder mehrere Cookies des Anbieters gesetzt.

Name econda
Zweck Measure with Visitor Cookie emos_jcvid
Externe Medien

Inhalte von externen Medienplattformen werden standardmäßig blockiert. Wenn Cookies von externen Medien akzeptiert werden, bedarf der Zugriff auf diese Inhalte keiner manuellen Zustimmung mehr.

Name YouTube
Zweck Zeige YouTube Inhalte
Name Twitter
Zweck Twitter Feeds aktivieren

Publications 2010

Benner A., Zucknick M., Hielscher T., Ittrich C., Mansmann U.: High-dimensional Cox models: The choice of penalty as part of the model building process. Biometr.J. 52 (1) 50-69, 2010.

Combs S.E., Burkholder I., Edler L., Rieken G., Habermehl D., Jäkel O., Haberer T., Haselmann R., Unterberg A., Wick W., Debus J.: Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: the CINDERELLA trial NCT01166308. BMC Cancer 10 533 (8p.), 2010.

Combs S.E., Edler L., Burkholder I., Rieken G., Habermehl D., Jäkel O., Haberer T., Unterberg A., Wick W., Debus J.: Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: The MARCIE trial. BMC Cancer 10 (1) 615(18p.), 2010.

DeCarlo C.A., Severini A., Edler L., Escott N., Lambert P.F., Ulanova M., Zehbe I.: IFN-kappa, a novel type 1 IFN, is undetectable in HPV-positive human cervical keratinocytes. Lab.Invest. 90 1482-1491, 2010.

Diercks A.K., Schwab A., Rittgen W., Kruspel A., Heuss E., Schenkel J.: Environmental influences on the production of pre-implantation embryos. Theriogenol. 73 (9) 1238-1243, 2010.

Dietrich S., Schönland S.O., Benner A., Bochtler T., Kristen A.V., Beimler J., Hund E., Zorn M., Goldschmidt H., Ho A.D., Hegenbart U.: Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement. Blood 116 (4) 522-528, 2010.

Edler L.: EFSA Panel on Contaminants in the food chain (CONTAM): Scientific Opinion on marine biotoxins in shellfish - Emerging toxins: Ciguatoxin group. EFSA J. 8 (6) 1627(38p.), 2010.

Edler L.: EFSA Panel on Contaminants in the food chain (CONTAM): Scientific opinion on marine biotoxins in shellfish - Cyclic imines (spirolides, gymnodimines, pinnatoxins and pteriatoxins. EFSA J. 8 (6) 1628(39p.), 2010.

Edler L., Sehrt D., Scheulen M.E.: Preface: 10 years CESAR anticancer drug research. The 7th CESAR annual meeting 2009. Int.J.Clin.Pharm.Therap. 48 (7) 435-439, 2010.

Edler L.: EFSA Panel on Contaminants in the food chain (CONTAM): Scientific opinion on melamine in food and feed. EFSA J. 8 (4) 1573(145p.), 2010.

Edler L.: EFSA Panel on Contaminants in the food chain (CONTAM): Scientific opinion on lead in food. EFSA J. 8 (4) 1570(147p.), 2010.

Edler L.: EFSA Panel on Contaminants in the food chain (CONTAM): Scientific Opinion on the safety and efficacy of using recycled hot water as a decontamination technique for meat carcasses. EFSA J. 8 (9) 1827(69p.), 2010.

Edler L.: EFSA Panel on Contaminants in the food chain (CONTAM): Scientific opinion on polybrominated biphenyls (PBBs) in food. EFSA J. 8 (10) 1789(151p.), 2010.

Edler L.: EFSA Panel on Contaminants in the food chain (CONTAM): Scientific opinion on possible public health risks for infants and young children from the presence of nitrates in leafy vegetables. EFSA J. 8 (12) 1935(42p.), 2010.

Edler L.: EFSA Panel on Contaminants in the food chain (CONTAM): Statement on further elaboration of the consumption figure of 400 g shellfish meat on the basis of new consumption data. EFSA J. 8 (8) 1706(20p.), 2010.

Edler L.: EFSA Panel on Contaminants in the food chain (CONTAM): Statement on recent scientific information on the toxicity of Ochratoxin A. EFSA J. 8 (6) 1626(7p.), 2010.

Edler L.: EFSA Panel on Contaminants in the food chain (CONTAM), EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) and EFSA Panel on Plant Health (PLH): Scientific opinion on the effect on public or animal health or on the environment on the presence of seeds of Ambrosia spp. in animal feed. EFSA J. 8 (6) 1566(37p.), 2010.

Edler L.: EFSA Panel on Contaminants in the food chain (CONTAM): Scientific Opinion on marine biotoxins in shellfish - Emerging toxins: Brevetoxin group. EFSA J. 8 (7) 1677(29p.), 2010.

Eichinger M., Walterspacher S., Scholz T., Tetzlaff R., Puderbach M., Tetzlaff K., Kopp-Schneider A., Ley S., Choe K., Kauczor H.U., Sorichter S.: Glossopharyngeal insufflation and pulmonary hemodynamics in elite breath hold divers. Med.Sci.Sports Exerc. 42 (9) 1688-1695, 2010.

Fechtner K., Hillengass J., Delorme S., Heiss C., Neben K., Goldschmidt H., Kauczor H.U., Weber M.A.: Staging monoclonal plasma cell disease: comparison of the Durie-Salmon and the Durie-Salmon PLUS staging systems. Radiology 257 (1) 195-204, 2010.

Freyberger A., Weimer M., Tran H.S., Ahr H.J.: Assessment of a recombinant androgen receptor binding assay: Initial steps towards validation. Reprod.Toxicol. 30 (1-ReProTect special issue) 2-8, 2010.

Freyberger A., Witters H., Weimer M., Lofink W., Berckmans P., Ahr H.J.: Screening for (anti)androgenic properties using a standard operation protocol based on the human stably transfected androgen sensitive PALM cell line. First steps towards validation. Reprod.Toxicol. 30 (1-ReProTect special issue) 9-17, 2010.

Freyberger A., Weimer M., Lofink W., Ahr H.J.: Short-term dynamic culture of rat testicular fragments as a model to assess effects on steroidogenesis-Potential use and limitations. Reprod.Toxicol. 30 (1-ReProTect special issue) 36-43, 2010.

Freyberger A., Wilson V., Weimer M., Tan S., Tran H.-S., Ahr H.J.: Assessment of a robust model protocol with accelerated throughput for a human recombinant full length estrogen receptor- binding assay: Protocol optimization and intralaboratory assay performance as initial steps towards validation. Reprod.Toxicol. 30 (1-ReProTect specical issue) 50-59, 2010.

Gribov A., Sill M., Lück S., Rücker F., Döhner K., Bullinger L., Benner A., Unwin A.: SEURAT: visual analytics for the integrated analysis of microarray data. BMC Med.Genom. 3 21, 2010.

Groos J., Kopp-Schneider A.: Application of a two-phenotype color-shift model with heterogeneous growth to a rat hepatocarcinogenesis experiment. Math.Biosci. 224 (2) 95-100, 2010.

Grund N., Maier P., Giordano F.A., Appelt J.U., Zucknick M., Li L., Wenz F., Zeller W.J., Frühauf S., Allgayer H., Laufs S.: Analysis of self-inactivating lentiviral vector integration sites and flanking gene expression in human peripheral blood progenitor cells after alkylator chemotherapy. Hum.Gene Ther. 21 (8) 943-956, 2010.

Hassel J.C., Sucker A., Edler L., Kurzen H., Moll I., Stresemann C., Spieth K., Mauch C., Rass K., Dummer R., Schadendorf D.: MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome. Br.J.Cancer 103 (6) 820-826, 2010.

Hielscher T., Zucknick M., Werft W., Benner A.: On the prognostic value of survival models with application to gene expression signatures. Stat.Med. 29 (7-8) 818-829, 2010.

Hillengass J., Fechtner K., Weber M.A., Bäuerle T., Ayyaz S., Heiss C., Hielscher T., Möhler T.M., Egerer G., Neben K., Ho A.D., Kauczor H.U., Delorme S., Goldschmidt H.: Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma. J.Clin.Oncol. 28 (9) 1606-1610, 2010.

Hof H., Zgoda J., Nill S., Hoess A., Kopp-Schneider A., Herfarth K., Debus J., Plathow C.: Time- and dose-dependency of radiographic normal tissue changes of the lung after stereotactic radiotherapy. Int.J.Radiat.Oncol.Biol.Phys. 77 (5) 1369-1374, 2010.

Hoffmann M., Ihloff A.S., Görögh T., Weise J.B., Fazel A., Krams M., Rittgen W., Schwarz E., Kahn T.: p16(INK4a) overexpression predicts translational active human papillomavirus infection in tonsillar cancer. Int.J.Cancer 127 (7) 1595-1602, 2010.

Hothorn L.A., Sill M., Schaarschmidt F.: Evaluation of incidence rates in pre-clinical studies using a Williams-type procedure. Int.J.Biostat. 6 (1) article 15, 2010.

Huszar M., Pfeifer M., Schirmer U., Kiefel H., Konecny G.E., Ben-Arie A., Edler L., Münch M., Müller-Holzner E., Jerabek-Klestil S., Abdel-Azim S., Marth C., Zeimet A.G., Altevogt P., Fogel M.: Upregulation of L1CAM is linked to loss of hormone receptors and E-Cadherin in aggressive subtypes of endometrial carcinomas. J.Pathol. 220 (5) 551-561, 2010.

Jakubowska A., Gronwald J., Menkiszak J., Gorski B., Huzarski T., Byrski T., Toloczko-Grabarek A., Gilbert M., Edler L., Zapatka M., Eils R., Lubinski J., Scott R.J., Hamann U.: BRCA1 associated breast and ovarian cancer risks in Poland: No association with commonly studied polymorphisms. Breast Cancer Res.Treat. 119 (1) 201-211, 2010.

Kienle D., Benner A., Läufle C., Winkler D., Bühler A., Zenz T., Habermann A., Jäger U., Lichter P., Dalla-Favera R., Döhner H., Stilgenbauer S.: Gene expression factors as predictors of genetic risk and survival in chronic lymphocytic leukemia. Haematologica 95 (1) 102-109, 2010.

Korshunov A., Witt H., Hielscher T., Benner A., Remke M., Ryzhova M., Milde T., Bender S., Wittmann A., Schöttler A., Kulozik A., Witt O., Deimling A.v., Lichter P., Pfister S.: Molecular staging of intracranial ependymoma in children and adults. J.Clin.Oncol. 28 (19) 3182-3190, 2010.

Korshunov A., Remke M., Werft W., Benner A., Ryzhova M., Witt H., Sturm D., Wittmann A., Schöttler A., Felsberg J., Reifenberger G., Rutkowski S., Scheurlen W., Kulozik A.E., Deimling A.v., Lichter P., Pfister S.M.: Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification. J.Clin.Oncol. 28 (18) 3054-3060, 2010.

Korshunov A., Remke M., Gessi M., Ryzhova M., Hielscher T., Witt H., Tobias V., Buccoliero A.M., Sardi I., Gardiman M.P., Bonnin J., Scheithauer B., Kulozik A., Witt O., Mork S., Deimling A.v., Wiestler O.D., Giangaspero F., Rosenblum M., Pietsch T., Lichter P., Pfister S.M.: Focal genomic amplification at 19q13.42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettes. Acta Neuropathol. 120 (2) 253-260, 2010.

Kretz C.C., Norpo M., Abeler-Dörner L., Linke B., Haust M., Edler L., Krammer P.H., Kuhn A.: Anti-annexin 1 antibodies: a new diagnostic marker in the serum of patients with discoid lupus erythematosus. Exp.Dermatol. 19 (10) 919-921, 2010.

Letellier E., Kumar S., Sancho-Martinez I., Krauth S., Funke-Kaiser A., Laudenklos S., Konecki K., Klussmann S., Corsini N.S., Kleber S., Drost N., Neumann A., Levi-Strauss M., Brors B., Gretz N., Edler L., Fischer C., Hill O., Thiemann M., Biglari B., Karray S., Martin-Villalba A.: CD95-Ligand on peripheral myeloid cells activates Syk kinase to trigger their recruitment to the inflammatory site. Immunity 32 (2) 240-252, 2010.

Luciano A.M., Franciosi F., Lodde V., Corbani D., Lazzari G., Crotti G., Galli C., Pellizzer C., Bremer S., Weimer M., Modina S.C.: Transferability and inter-laboratory variability assessment of the in vitro bovine oocyte maturation (IVM) test within ReProTect. Reprod.Toxicol. 30 (1-ReProTect special issue) 81-88, 2010.

Marme F., Werft W., Benner A., Burwinkel B., Sinn P., Sohn C., Lichter P., Hahn M., Schneeweiss A.: FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer. Ann.Oncol. 21 (8) 1636-1642, 2010.

Märten A., Büchler M.W., Werft W., Wente M.N., Kirschfink M., Schmidt J.: Soluble iC3b as an early marker for pancreatic adenocarcinoma is superior to CA19.9 and radiology. J.Immunother. 33 (2) 219-224, 2010.

McClanathan F., Hielscher T., Rieger M., Hensel M., Neben K., Hillengass J., Herfarth K., Ho A.D., Witzens-Harig M.: Clinical outcome of patients with follicular lymphoma and bulky disease after rituximab-CHOP immunochemotherapy with and without consolidating radiotherapy. Eur.J.Haematol. 85 (1) 11-19, 2010.

Milde T., Öhme I., Korshunov A., Kopp-Schneider A., Remke M., Northcott P., Deubzer H.E., Lodrini M., Taylor M.D., Deimling A.v., Pfister S., Witt O.: HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth. Clin.Cancer Res. 16 (12) 3240-3252, 2010.

Myllynen P., Mathiesen L., Weimer M., Annola K., Immonen E., Karttunen V., Kummu M., Morck T.L., Kolstrup-Sogaard-Nielsen J., Ehlert-Knudsen L., Vähäkangas K.: Preliminary interlaboratory comparison of the ex vivo dual human placental perfusion system. Reprod.Toxicol. 30 (1-ReProTect special issue) 94-102, 2010.

Neben K., Jauch A., Bertsch U., Heiss C., Hielscher T., Seckinger A., Mors T., Müller N.Z., Hillengass J., Raab M.S., Ho A.D., Hose D., Goldschmidt H.: Combining chromosomal aberrations t(4;14) and del(17p13) with ISS allows a stratification of myeloma patients undergoing autologous stem cell transplantation. Haematologica 95 (7) 1150-1157, 2010.

Paige A.J., Zucknick M., Janczar S., Paul J., Mein C.A., Taylor K.J., Stewart M., Gourley C., Richardson S., Perren T., Ganesan T.S., Smyth J.F., Brown R., Gabra H.: WWOX tumour suppressor gene polymorphisms and ovarian cancer pathology and prognosis. Eur.J.Cancer 46 (4) 818-825, 2010.

Paschka P., Schlenk R.F., Gaidzik V.I., Habdank M., Krönke J., Bullinger L., Späth D., Kayser S., Zucknick M., Götze K., Horst H.A., Germing U., Döhner H., Döhner K.: IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication. J.Clin.Oncol. 28 (22) 3636-3643, 2010.

Pfaff E., Remke M., Sturm D., Benner A., Witt H., Milde T., von Büren A.O., Wittmann A., Schöttler A., Jorch N., Graf N., Kulozik A.E., Witt O., Scheurlen W., von Deimling A., Rutkowski S., Taylor M.D., Tabori U., Lichter P., Korshunov A., Pfister S.M.: TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma. J.Clin.Oncol. 28 (35) 5188-5196, 2010.

Roy E., Togbe D., Holdorf A.D., Trubetskoy D., Nabti S., Küblbeck G., Schmitt S., Kopp-Schneider A., Leithäuser F., Möller P., Bladt F., Hämmerling G., Arnold B., Pawson T., Tafuri A.: Fine tuning of the threshold of T cell selection by the Nck adapters. J.Immunol. 185 7518-7526, 2010.

Roy E., Togbe D., Holdorf A.D., Trubetskoy D., Nabti S., Küblbeck G., Klevenz A., Kopp-Schneider A., Leithäuser F., Möller P., Bladt F., Hämmerling G., Arnold B., Pawson T., Tafuri A.: Nck adaptors are positive regulators of the size and sensitivity of the T-cell repertoire. PNAS 107 (35) 15529-15534, 2010.

Schäfer W.R., Fischer L., Deppert W.R., Hanjalic-Beck A., Seebacher L., Weimer M., Zahradnik H.P.: In vitro-Ishikawa cell test for assessing tissue-specific chemical effects on human endometrium. Reprod.Toxicol. 30 (1-ReProTect special issue) 89-93, 2010.

Schenk B., Weimer M., Bremer S., van der Burg B., Cortvrindt R., Freyberger A., Lazzari G., Pellizzer C., Piersma A., Schäfer W.R., Seiler A., Witters H., Schwarz M.: The ReProTect Feasibility Study, a novel comprehensive in vitro approach to detect reproductive toxicants. Reprod.Toxicol. 30 (1-ReProTect special issue) 200-218, 2010.

Scherf D., Dally H., Müller P., Werle-Schneider G., Jäger B., Edler L., Tüngerthal S., Fischer J.R., Drings P., Bartsch H., Risch A.: Single nucleotide polymorphisms in matrix metalloproteinase genes and lung cancer chemotherapy response and prognosis. Eur.Respir.J. 35 (2) 381-390, 2010.

Schlenk R.F., Döhner K., Mack S., Stoppel M., Kiraly F., Götze K., Hartmann F., Horst H.A., Koller E., Petzer A., Grimminger W., Kobbe G., Glasmacher A., Salwender H., Kirchen H., Haase D., Kremers S., Matzdorff A., Benner A., Döhner H.: Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A. J.Clin.Oncol. 28 (30) 4642-4648, 2010.

Schröder C., Jacob A., Tonack S., Radon T.P., Sill M., Zucknick M., Rüffer S., Costello E., Neoptolemos J.P., Crnogorac-Jurcevic T., Bauer A., Fellenberg K., Hoheisel J.D.: Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies. Mol.Cell.Proteom. 9 (6) 1271-1280, 2010.

Sill M., Schröder C., Hoheisel J.D., Benner A., Zucknick M.: Assessment and optimisation of normalisation methods for dual-colour antibody microarrays. BMC Bioinformatics 11 (1) 556, 2010.

Steimer J.L., Dahl S.G., De Alwis D.P., Gundert-Remy U., Karlsson M.O., Martinkova J., Aarons L., Ahr H.J., Clairambault J., Freyer G., Friberg L.E., Kern S.E., Kopp-Schneider A., Ludwig W.D., Nicolao G.D., Rocchetti M., Troconiz I.F.: Modelling the genesis and treatment of cancer: The potential role of physiologically based pharmacodynamics. Eur.J.Cancer 46 (1) 21-32, 2010.

Strumberg D., Schultheis B., Scheulen M.E., Hilger R.A., Krauss J., Marschner N., Lordick F., Bach F., Reuter D., Edler L., Mross K.: Safety, efficacy and pharmacokinetics of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer. Int.J.Clin.Pharm.Therap. 48 (7) 473-475, 2010.

Thöm I., Andritzky B., Schuch G., Burkholder I., Edler L., Johansen J.S., Bokemeyer C., Schumacher U., Laack E.: Elevated pre-treatment serum concentration of YKL-40 - an independent prognostic biomarker for poor survival in patients with metastatic non-small cell lung cancer. Cancer 116 (17) 4114-4121, 2010.

Traenka C., Remke M., Korshunov A., Bender S., Hielscher T., Northcott P., Witt H., Ryzhova M., Felsberg J., Benner A., Riester S., Scheurlen W., Grunewald T.G.P., von Deimling A., Kulozik A., Reifenberger G., Taylor M.D., Lichter P., Butt E., Pfister S.M.: Role of LIM and SH3 protein 1 (LASP1) in the metastatic dissemination of medulloblastoma. Cancer Res. 70 (20) 8003-8014, 2010.

Uibel F., Mühleisen A., Köhle C., Weimer M., Stummann T.C., Bremer S., Schwarz M.: ReProGlo: A new stem cell-based reporter assay aimed to predict embryotoxic potential of drugs and chemicals. Reprod.Toxicol. 30 (1-ReProTect special issue) 103-112, 2010.

van der Burg B., Winter R., Man H.-Y., Vangenechten C., Berckmans P., Weimer M., Witters H., van der Linden H.: Optimization and prevalidation of the in vitro AR CALUX method to test androgenic and antiandrogenic activity of compounds. Reprod.Toxicol. 30 (1-ReProTect specical issue) 18-24, 2010.

van der Burg B., Winter R., Weimer M., Berckmans P., Suzuki G., Gijsbers L., Jonas A., van der Linden H., Witters H., Aarts J., Legler J., Kopp-Schneider A., Bremer S.: Optimization and prevalidation of the in vitro ERa CALUX method to test estrogenic and antiestrogenic activity of compounds. Reprod.Toxicol. 30 (1-ReProTect special issue) 73-80, 2010.

Villani P., Spano M., Pacchierotti F., Weimer M., Cordelli E.: Evaluation of a modified comet assay to detect DNA damage in mammalian sperm exposed in vitro to different mutagenic compounds. Reprod.Toxicol. 30 (1-ReProTect specical issue) 44-49, 2010.

Wagner K., Damm F., Göhring G., Görlich K., Heuser M., Schäfer I., Ottmann O., Lübbert M., Heit W., Kanz L., Schlimok G., Raghavachar A.A., Fiedler W., Kirchner H.H., Brugger W., Zucknick M., Schlegelberger B., Heil G., Ganser A., Krauter J.: Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor. J.Clin.Oncol. 28 (14) 2356-2364, 2010.

Weinhold N., Moreaux J., Raab M.S., Hose D., Hielscher T., Benner A., Meissner T., Ehrbrecht E., Brough M., Jauch A., Goldschmidt H., Klein B., Moos M.: NPM1 is overexpressed in hyperdiploid multiple myeloma due to a gain of chromosome 5 but is not delocalized to the cytoplasm. Genes, Chromosomes & Cancer 49 (4) 333-341, 2010.

Werft W., Benner A.: glmperm: a permutation of regressor residuals test for inference in generalized linear models. The R Journal 2 (1) 39-43, 2010.

Winkler D., Schneider C., Zucknick M., Bogelein D., Schulze K., Zenz T., Mohr J., Philippen A., Huber H., Buhler A., Habermann A., Benner A., Döhner H., Stilgenbauer S., Mertens D.: Protein expression analysis of chronic lymphocytic leukemia defines the effect of genetic aberrations and uncovers a correlation of CDK4, P27 and P53 with hierarchical risk. Haematologica 95 (11) 1880-1888, 2010.

Winterstein M., Münter M.W., Burkholder I., Essig M., Kauczor H.U., Weber M.A.: Partially resected gliomas: diagnostic performance of fluid-attenuated inversion recovery MR imaging for detection of progression. Radiology 254 (3) 907-916, 2010.

Witters H., Freyberger A., Smits K., Vangenechten C., Lofink W., Weimer M., Bremer S., Ahr P.H.J., Berckmans P.: The assessment of estrogenic or anti-estrogenic activity of chemicals by the human stably transfected estrogen sensitive MELN cell line: Results of test performance and transferability. Reprod.Toxicol. 30 (1-ReProTect special issue) 60-72, 2010.

Wörner S.M., Yuan Y.P., Benner A., Korff S., Knebel-Doeberitz M.v., Bork P.: SelTarbase, a database of human mononucleotide-microsatellite mutations and their potential impact to tumorigenesis and immunology. Nucl.Acids Res. 38 D682-D689, 2010.

Zechmann C.M., Simpfendörfer T., Giesel F.L., Zamecnik P., Thieke C., Hielscher T., Meinzer H.P., Delorme S.: Comparison of peripheral zone and central gland volume in patients undergoing intensity-modulated radiotherapy. J.Comput.Assist.Tomogr. 34 (5) 739-745, 2010.

Zenz T., Benner A., Stilgenbauer S.: MDM2 promotor polymorphism and disease characteristics in CLL. Leukem.Res. 34 (5) 578-579, 2010.

Zwick S., Brix G., Tofts P.S., Strecker R., Kopp-Schneider A., Laue H., Semmler W., Kiessling F.: Simulation-based comparison of two approaches frequently used for dynamic contrast-enhanced MRI. Eur.Radiol. 20 (2) 432-442, 2010.

to top
powered by webEdition CMS